Hyperprolactinemia. E22.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM E22.1 became effective on October 1, 2018. This is the American ICD-10-CM version of E22.1 - other international versions of ICD-10 E22.1 may differ.
Full Answer
Oct 01, 2021 · Hyperprolactinemia. E22.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E22.1 became effective on October 1, 2021. This is the American ICD-10-CM version of E22.1 - other international versions of ICD-10 E22.1 may differ.
ICD-10-CM Diagnosis Code E22.1 [convert to ICD-9-CM] Hyperprolactinemia. Hyperprolactinemia (high prolactin hormone level); code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) ICD-10-CM Diagnosis Code E22.1. Hyperprolactinemia.
2021/2022 ICD-10-CM Index > 'Prolactinoma'. Toggle navigation.
E22.1 is a billable diagnosis code used to specify a medical diagnosis of hyperprolactinemia. The code E22.1 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions. The ICD-10-CM code E22.1 might also be used to specify conditions or terms like drug-induced hyperprolactinemia, familial …
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...